The 10-member Subject Expert Committee of India’s Central Drug Standard Control Organisation on Friday approved emergency use authorisation of the Oxford-AstraZeneca coronavirus vaccine ‘Covishield’.   The expert panel had convened a meeting to take a call on the emergency use authorisation sought by the Serum Institute of India, the manufacturer of Covishield, and Bharat Biotech … Continue reading Expert Committee of India’s Drug approved emergency use of vaccine “Covishield”